Pamidronate Disodium Injection Shortage
Last Updated: December 3, 2018
Status: Resolved
Reason for the Shortage
-
- Areva has pamidronate powder for injection available.
- Mylan Institutional did not provide a reason for the shortage.
- Pfizer had pamidronate on shortage due to manufacturing delays.
Available Products
-
- Pamidronate disodium lyophilized powder for injection, Areva, 30 mg, vial, 1 count, NDC 59923-0601-10
- Pamidronate disodium lyophilized powder for injection, Areva, 90 mg, vial, 1 count, NDC 59923-0603-10
- Pamidronate disodium injection, Mylan Institutional, 3 mg/mL, 10 mL vial, 1 count, NDC 67457-0430-10
- Pamidronate disodium injection, Mylan Institutional, 9 mg/mL, 10 mL vial, 1 count, NDC 67457-0446-10
- Pamidronate disodium injection, Pfizer, 3 mg/mL, 10 mL vial, 1 count, NDC 61703-0324-18
- Pamidronate disodium injection, Pfizer, 6 mg/mL, 10 mL vial, 1 count, NDC 61703-0325-18
- Pamidronate disodium injection, Pfizer, 9 mg/mL, 10 mL vial, 1 count, NDC 61703-0326-18
Estimated Resupply Dates
-
- All marketed presentations are available.
Updated
Updated December 3, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 6, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.